Contract Research Organisations (CROs) - Articles and news items

Rainin TerraRacks enhance process security for CROs

Rainin TerraRacks enhance process security for CROs

Supplier news / 3 November 2016 / METTLER TOLEDO AG

Pelago Bioscience in Solna, Sweden, is taking advantage of the enhanced process security and convenience offered by METTLER TOLEDO’s Rainin TerraRack™ pipette tip racks…

Sheraz Gul

The evolution of the Contract Research Organisation and the future of the pharmaceutical industry

Contract Research, Issue 1 2013 / 20 February 2013 / Kevin Lustig and Maria Thompson, Assay Depot, Sheraz Gul, European ScreeningPort GmbH,

This article discusses how the pharmaceutical industry can leverage its competencies in outsourcing to accelerate time to market, improve quality and increase innovation at all stages of the drug discovery and development process. The pharmaceutical industry is being battered by a perfect storm of not just one but three major issues, any of which on its own would prove a tough nut to crack…

Outsourcing in early drug discovery: Evolution and opportunities

Contract Research, Issue 2 2012 / 26 April 2012 / Jayshree Mistry, Paul Lloyd, Kevin Oliver and Peter North, GlaxoSmithKline R&D and Duncan Judd, Awridian

This article describes the evolution of outsourcing within early drug discovery at GlaxoSmithKline (GSK), specifically for chemistry services applied to developing a compound from the screening hit through lead optimisation. It will touch on different business models, factors to consider when selecting potential CROs, the benefits of outsourcing and CRO management…



Videos / 9 March 2012 / Accelrys

Learn more about HEOS® by SCYNEXIS – a SaaS workspace in which multiple, disparate companies, academic collaborators or CROs can exchange scientific data securely and in real-time.

CROs as a strategic fit – the one stop shop for R&D services

Industry Focus 2008, Past issues / 7 April 2008 /

Contract Research Organisations (CROs) provide independent development services for pharma, biotechnology, and medical device markets. Services offered by CROs have evolved from providing basic support, to a wide range of services catering to various needs of the market and the sponsors. The United States is the world’s largest market for drugs and accounts for almost half of the research and development (R&D) spending in pharmaceutical and biotechnology markets. Hence, CROs have a strong presence in this market and have invested in new facilities and technologies to cater to a wide range of sponsors. It is estimated that only 25 percent of the R&D activity is currently being outsourced to these organisations. This is likely to double in the coming years due to mounting pressure on the pharmaceutical companies to increase productivity of the cost intensive drug development process.


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...